Quick Takeaways
- venBio Global Strategic Fund V, L.P. filed SCHEDULE 13D for ACHIEVE LIFE SCIENCES, INC. Common Stock, par value $0.001 per share (ACHV).
- Disclosed ownership: 10%.
- Date of event: 15 Apr 2026.
venBio Global Strategic Fund V, L.P. - 15 Apr 2026 SCHEDULE 13D Report for ACHIEVE LIFE SCIENCES, INC. Common Stock, par value $0.001 per share (ACHV)
- Filing Manager
- venBio Global Strategic Fund V, L.P.
- Reporting Manager
- venBio Global Strategic Fund V, L.P.
- Symbol
- ACHV
- Shares outstanding
- 107,480,651 shares
- Disclosed Ownership
- 10,737,317 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13D
- Filing time
- 27 Apr 2026, 17:28:51 UTC
- Date of event
- 15 Apr 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"venBio Global Strategic Fund V, L.P. disclosed 10% ownership in ACHIEVE LIFE SCIENCES, INC. Common Stock, par value $0.001 per share (ACHV) on 15 Apr 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 27 Apr 2026, 17:28.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (2)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| venBio Global Strategic Fund V, L.P. | 10% | 10,737,317 | 0 | 10,737,317 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Aaron Royston, Corey Goodman, and Richard Gaster, Members of the General Partner | 0002029777 |
| venBio Global Strategic GP V, LLC | 10% | 10,737,317 | 0 | 10,737,317 | /s/ David Pezeshki | David Pezeshki, as attorney-in-fact for Aaron Royston, Corey Goodman, and Richard Gaster, Members |